• Dr. Mohammed Al-Omran co-inventor of U.S. patented method to prevent, treat heart disease

    Click on image to read full story...

  • KING SAUD UNIVERSITY, LI KA SHING INSTITUTE COLLABORATION A SUCCESS STORY

    Click on image to read full story...

Mohammed Al-Omran – MD, MSc, FRCSC

KSU Administrative and Research Lead, KSU Medical Research Program

Scientist, Keenan Research Centre, Li Ka Shing Knowledge Institute of St. Michael’s Hospital
 
Associate Professor, Department of Surgery, King Saud University
 
Staff Surgeon, Division of Vascular Surgery, King Khalid University Hospital
 
KSU Research Chair in Peripheral Vascular Disease, Department of Surgery, King Saud University
 
                                        BIOGRAPHY
 Dr Mohammed Al-Omran is a general and vascular surgeon. He  completed his Medical degree (MD) from King Saud University, a master of Science (MSc) degree in Clinical Epidemiology  fromUniversityofTorontoand clinical residency and fellowship training in general and vascular surgery fromUniversityofToronto. He is an Associate Professor in the Department of Surgery atKingSaudUniversityand a Scientist at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital. His research interests are focused on atherosclerosis bench to bedside with special interest in peripheral arterial disease. Dr Al-Omran has published over 50 peer-reviewed papers and over 120 abstracts, with several papers appearing in the New England Journal of Medicine, Proceeding of National Academy of Science, Nature Communication, Circulation, and the Journal of Vascular Surgery. Dr Al-Omran was awarded the Golden Medal for the top 10 researchers at KingSaudUniversityin 2011 and the Award for Pioneers of the Saudi Medical Invention by the International Medical Sciences Colleges in 2010. 
 
PUBLICATIONS
 
Please find below a list of selected publications that Dr. Mamdani has authored and or been involved in through the KSU Medical Research Program. For additional publications, please click on the PubMed link.
 
  1. Al-Omran M, Aljabri B. Update on Gangrene. BMJ Point of Care and Best Practice 2011
  2. Al-Omran M, Singh, KK, Shukla, PC, Quan, A, Lovren, F, Pan, Y, Wolfstadt, JI, Gupta, M, Leong-Poi, H, Teoh, H and Verma, S. Anti-ERBB2 induces cardiomyocyte death and p53 activation.  Am J Physiol Heart Circ Physiol. 2011 (In Press).
  3. Al-Omran M, Verma S, Lindsay TF. Suboptimal Use of Risk Reduction Therapy in Patients with Peripheral Arterial Disease: A Major Teaching Hospital Experience.  Annals of Saudi Medicine 2011; 31(4):371-5.
  4. Singh K, Shukla P, Quan A, Lovren F, Pan Y, Wolfstadt J, Gupta M, Al-Omran M, Leong-Poi H, Teoh H, Verma S. Herceptin, a recombinant humanized anti-ERBB2 monoclonal antibody, induces cardiomyocyte death. Biochemical and Biophysical Research Communications 2011;411(2):421-6
  5. Al-Mubarak HA, Alamri TM, Aljabab SA, Atteya M, Quan A, Teoh H, Shukla PC, Verma S, Aldahmash A, Aljabri B, Napoli C, Al-Omran M. Effects on duration of post-operative ischemia and patterns of blood flow recovery in different conditions of mouse hind limb ischemia. Vasc Cell. 2011 Jun 14;3(1):14.
  6. Binsaeed AA, Al-Khedhairy AA, Mandil AM, Shaikh SA, Qureshi R, Al-Khattaf AS, Habib HA, Alam AA, Al-Ansary LA, Al-Omran M. A validation study comparing the sensitivity and specificity of the new Dr.KSU H1N1 RT-PCR kit with real-time RT-PCR for diagnosing influenza A (H1N1). Annals of Saudi Medicine 2011; 31(4):351-5.
  7. Shukla PC, Singh KK, Quan A, Al-Omran M, Teoh H, Lovren F, Cao L, Rovira II, Pan Y, Brezden-Masley C, Yanagawa B, Gupta A, Deng C-X, Coles JG, Leong-Poi H, Stanford WL, Parker TG, Schneider MD, Finkel T, Verma S.  BRCA1 is an Essential Regulator of Heart Function and Survival following Myocardial Infarction.  Nature Communications (In press)
  8. Singh K, Shukla P, Quan A, Lovren F, Pan Y, Wolfstadt J, Gupta M, Al-Omran M, Leong-Poi H, Teoh H, Verma S. Herceptin, a recombinant humanized anti-ERBB2 monoclonal antibody, induces cardiomyocyte death. Biochemical and Biophysical Research Communications 2011;411(2):421-6
  9. Singh KK, Shukla PC, Quan A, Lovren F, Pan Y, Wolfstadt JI, Gupta M, Al-Omran, M, Leong-Poi H, Teoh H, Verma S. Herceptin, a recombinant humanized anti-ERBB2 monoclonal antibody, induces cardiomyocyte death.  Biochem Biophys Res Commun: 2011: 411: pp 421-6.
  10. Singh, KK, Shukla, PC, Al-Omran M, Quan, A, Lovren, F, Pan, Y, Wolfstadt, JI, Gupta, M, Leong-Poi, H, Teoh, H and Verma, S. BRCA2 deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failure. Journal of Biological Chemistry (JBC). 2011 (In Press).
  11. Al-Omran M, Albalawi ZH, Tashkandi MF, Al-Ansary LA.Update: Enteral versus parenteral nutrition for acute pancreatitis. In: The Cochrane Database Syst Rev. 2010 Jan 20;(1):CD002837.
  12. Altoijry A, Mamdani M, Al-Omran M. Trends in Abdominal Aortic Aneurysm Repair in the Era of Endovascular Technology inOntario. J Vasc Surg 2011Jan;53(1):227-8.
  13. Lovren F, Al-Omran M,  Pan Y, Quan A, Singh K, Shukla P, Gupta M,  Al-Omran M, Teoh H, Verma S.  Adropin is a Novel Regulator of Endothelial Function. Circulation 2010:122(11 Suppl):S185-92
  14. Lovren F, Al-Omran M,  Quan A, Singh K, Shukla P, Teoh H, Verma S. Adiponectin Primes Human Monocytes into Alternative Anti-inflammatory M2 Macrophages. Am J Physiol Heart Circ Physiol 2010: 299(3):H656-63.
  15. Lovren F, Pan Y, Quan A, Szmitko PE, Singh KK, Shukla PC, Gupta M, Chan L, Al-Omran M, Teoh H, Verma S.  Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages.  Am J Physiol: 2010: 299: pp H656-H663.
  16. Aljabri B, Al-Omran M. Medical Image: Giant Abdominal Aortic Aneurysm. New England Journal of Medicine 2009: 360(19)
  17. Al-Omran M, Mamdani M. Reply to: Might suboptimal use of statin therapy in the elderly be a blessing in disguise? J Vasc Surg. 2009
  18. Lovren F, Pan Y, Shukla PC, Quan A, Teoh H, Szmitko PE, Peterson MD, Al-Omran M, Verma S.Visfatin (nicotinomide phosphoribosyltransferase/pre-B cell colony-enhancing factor) activates eNOS via Akt andMAP kinases and improves endothelial cell function and angiogenesis in-vitro and in-vivo. Am J Physiol Endocrinol Metab. 2009: 296(6):E1440-E1449
  19. Al-Omran M, Albalawi ZH, Tashkandi MF, Al-Ansary LA.Update: Enteral versus parenteral nutrition for acute pancreatitis. In: The Cochrane Database Syst Rev. 2010 Jan 20;(1):CD002837.

More entries at PubMed

 
 
 
  • Click on image to view video

  • Click Image to View Information Booklet

%d bloggers like this: